Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 63Recruiting 24Unknown 20Terminated 17Not yet recruiting 4Active not recruiting 4Withdrawn 2Enrolling by invitation 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 2

Conditions

Leukemia, Myeloid, Acute 8Anemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 7Myelodysplastic Syndromes 7Primary Myelofibrosis 5Myeloproliferative Disorders 5Lymphoma, Follicular 5Leukemia 5Hematologic Neoplasms 5Anemia, Refractory, with Excess of Blasts 5Thrombocytopenia 4Polycythemia Vera 4Lymphoma, Mantle-Cell 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Lymphocytic, Chronic, B-Cell 4Febrile Neutropenia 4Congenital Abnormalities 4Anemia, Sickle Cell 4Anemia, Aplastic 4Thrombocythemia, Essential 3Pdgfra-Associated Chronic Eosinophilic Leukemia 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia, Neutrophilic, Chronic 3Leukemia, Myelomonocytic, Chronic 3Burkitt Lymphoma 3Blast Crisis 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Venous Thromboembolism × Classical hematology × Clear all
NCT01602432 2023-02-27

Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients

Ottawa Hospital Research Institute

Withdrawn
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT03988231 2021-10-08

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

University of Utah

Phase 4 Withdrawn
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡